Comparing nephrotoxicity of FK 506 and cyclosporine regimens after liver transplantation: preliminary results from US Multicenter trial. U.S. Multicenter Liver Study Group.

Suppr

超能文献

作者信息

Porayko M K, Gonwa T A, Klintmalm G B, Wiesner R H

机构信息

Liver Transplant Unit, Mayo Clinic, Rochester, MN 55905.

出版信息

Transplant Proc. 1995 Feb;27(1):1114-6.

PMID:7533358

Abstract

摘要

相似文献

Comparing nephrotoxicity of FK 506 and cyclosporine regimens after liver transplantation: preliminary results from US Multicenter trial. U.S. Multicenter Liver Study Group.

Transplant Proc. 1995 Feb;27(1):1114-6.

Nephrotoxicity of FK 506 and cyclosporine when used as primary immunosuppression in liver transplant recipients.FK506和环孢素在肝移植受者中用作初始免疫抑制时的肾毒性。

Transplant Proc. 1993 Feb;25(1 Pt 1):665-8.

Use of FK 506 for the prevention of recurrent allograft rejection after successful conversion from cyclosporine for refractory rejection. US Multicenter FK 506 Liver Study Group.将环孢素转换用于难治性排斥反应成功后，使用FK 506预防同种异体移植复发排斥反应。美国多中心FK 506肝脏研究小组。

Transplant Proc. 1993 Feb;25(1 Pt 1):635-7.

Hyperlipidemia after liver transplantation: long-term results of the FK506/cyclosporine A US Multicenter Trial. US Multicenter Study Group.

Transplant Proc. 1995 Feb;27(1):1121-3.

Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.使用普乐可复（FK506）作为肝移植后难治性排斥反应的挽救治疗。美国多中心FK506肝脏研究组。

Transplant Proc. 1993 Feb;25(1 Pt 1):679-88.

FK 506 rescue therapy: early conversion improves efficacy.

Transplant Proc. 1993 Apr;25(2):1990-1.

Comparison of FK 506- and cyclosporine-based immunosuppression: FK 506 therapy significantly reduces the incidence of acute, steroid-resistant, refractory, and chronic rejection whilst possessing a comparable safety profile. European FK 506 Multicenter Liver Study Group.

Transplant Proc. 1995 Feb;27(1):45-9.

Recurrent rejection following FK 506 rescue therapy for acute hepatic allograft rejection.FK506 挽救治疗急性肝移植排斥反应后出现反复排斥反应。

Transplant Proc. 1993 Apr;25(2):1988-9.

Whole-blood and plasma levels of FK 506 after liver transplantation: results from the US Multicenter Trial. FK506 Multicenter Study Group.

Transplant Proc. 1995 Feb;27(1):1124.

FK 506 rescue therapy: the rapidity of rejection reversal is related to the subsequent development of CMV disease.FK506挽救治疗：排斥反应逆转的速度与随后巨细胞病毒疾病的发生有关。

Transplant Proc. 1993 Apr;25(2):1992-3.

引用本文的文献

Comparison of whole-blood tacrolimus concentrations measured by different immunoassay systems.不同免疫分析系统测定的全血他克莫司浓度比较。

J Clin Lab Anal. 2018 Nov;32(9):e22587. doi: 10.1002/jcla.22587. Epub 2018 Jul 5.

Prophylaxis of chronic kidney disease after liver transplantation--experience from west China.肝移植后慢性肾脏病的预防——来自华西的经验。

World J Gastroenterol. 2012 Mar 7;18(9):991-8. doi: 10.3748/wjg.v18.i9.991.

Evidence for the immunosuppressive potential of calcineurin inhibitor-sparing regimens in liver transplant recipients with impaired renal function.肾功能受损的肝移植受者中钙调神经磷酸酶抑制剂减量方案免疫抑制潜力的证据。

J Transplant. 2011;2011:483728. doi: 10.1155/2011/483728. Epub 2011 Jul 6.

Immunosuppressive therapy in older cardiac transplant patients.老年心脏移植患者的免疫抑制治疗

Drugs Aging. 2007;24(11):913-32. doi: 10.2165/00002512-200724110-00004.

Primary adult liver transplantation under tacrolimus: more than 90 months actual follow-up survival and adverse events.他克莫司治疗下的成人原位肝移植：超过90个月的实际随访生存情况及不良事件

Liver Transpl Surg. 1999 Mar;5(2):144-50. doi: 10.1002/lt.500050209.

A prospective trial of tacrolimus (FK 506) in clinical heart transplantation: intermediate-term results.一项关于他克莫司（FK 506）用于临床心脏移植的前瞻性试验：中期结果。

J Thorac Cardiovasc Surg. 1996 Apr;111(4):764-72. doi: 10.1016/s0022-5223(96)70336-7.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验